SPC25 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.476900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.500200E-02
Normal-vs-Stage2
1.003420E-01
Normal-vs-Stage3
2.359000E-01
Normal-vs-Stage4
2.038800E-01
Stage1-vs-Stage2
2.267200E-01
Stage1-vs-Stage3
2.532000E-01
Stage1-vs-Stage4
2.226200E-01
Stage2-vs-Stage3
6.574200E-01
Stage2-vs-Stage4
5.163000E-01
Stage3-vs-Stage4
8.601400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.223500E-03
Normal-vs-AfricanAmerican
2.044400E-01
Normal-vs-Asian
1.338250E-01
Caucasian-vs-AfricanAmerican
6.486000E-01
Caucasian-vs-Asian
8.855600E-01
AfricanAmerican-vs-Asian
6.159200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.038800E-04
Normal-vs-Female
1.206830E-01
Male-vs-Female
3.835000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.671800E-01
Normal-vs-Age(41-60Yrs)
1.161000E-03
Normal-vs-Age(61-80Yrs)
1.394440E-01
Normal-vs-Age(81-100Yrs)
8.015900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.412800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.166600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.522200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.137400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.619600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.672000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.051200E-01
Normal-vs-Daily Drinker
9.014300E-02
Normal-vs-Weekly Drinker
1.738960E-01
Normal-vs-Occasional Drinker
4.649500E-02
Normal-vs-Social Drinker
1.553240E-01
Non Drinker-vs-Daily Drinker
9.064800E-01
Non Drinker-vs-Weekly Drinker
6.979200E-01
Non Drinker-vs-Occasional Drinker
1.938240E-01
Non Drinker-vs-Social Drinker
9.510400E-01
Daily Drinker-vs-Weekly Drinker
7.438800E-01
Daily Drinker-vs-Occasional Drinker
2.028000E-01
Daily Drinker-vs-Social Drinker
9.669400E-01
Weekly Drinker-vs-Occasional Drinker
2.488600E-01
Weekly Drinker-vs-Social Drinker
7.604600E-01
Occasional Drinker-vs-Social Drinker
2.038400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.180400E-01
Normal-vs-Grade 2
7.892600E-01
Normal-vs-Grade 3
8.496400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.071000E-01
Grade 1-vs-Grade 3
6.528600E-01
Grade 1-vs-Grade 4
9.180400E-01
Grade 2-vs-Grade 3
2.298600E-01
Grade 2-vs-Grade 4
7.892600E-01
Grade 3-vs-Grade 4
8.496400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.480300E-02
Normal-vs-NonDiabetic
9.591800E-02
Diabetic-vs-NonDiabetic
8.305400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.506300E-02
Normal-vs-NoPancreatitis
1.140870E-03
Pancreatitis-vs-NoPancreatitis
6.027000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.211580E-01
Normal-vs-N1
1.179760E-01
N0-vs-N1
1.843780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.58230000000459E-05
Normal-vs-TP53-NonMutant
4.037500E-04
TP53-Mutant-vs-TP53-NonMutant
4.240800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
